Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase

doi:10.3748/wjg.v9.i9.2030

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2609)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

255

HTML

2153

Figures (1-6)

195

Sum=2603

Sep 15, 2003 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 15, 2003; 9(9): 2030-2035
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2030

Full Size Figure Download Figure

Figure 6 Two possible pathways of antitumor effect of cantide. IAP: inhibitors of apoptosis, CDKIs: cycin-dependent kinase inhibitors, Apafs: apoptotic protease activating factors.

Citation: Du QY, Wang XB, Chen XJ, Zheng W, Wang SQ. Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase. World J Gastroenterol 2003; 9(9): 2030-2035
URL: https://www.wjgnet.com/1007-9327/full/v9/i9/2030.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i9.2030